Skip to main content

and
  1. Article

    Open Access

    Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis

    Triplet therapy, androgen receptor signaling inhibitors (ARSIs) plus docetaxel plus androgen-deprivation therapy (ADT), is a novel guideline-recommended treatment for metastatic hormone-sensitive prostate canc...

    Akihiro Matsukawa, Pawel Rajwa in International Journal of Clinical Oncology (2024)

  2. Article

    Open Access

    Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis

    Pembrolizumab is the standard for the first and second lines in treating metastatic urothelial carcinoma (UC). This systematic review and meta-analysis aimed to assess the value of pretreatment clinical charac...

    Takafumi Yanagisawa, Keiichiro Mori in International Journal of Clinical Oncology (2022)